Clincosm LogoSign in Get a demo

anaplastic oligodendroglioma

Showing 1 - 25 of 40
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Glioblastoma, Anaplastic Astrocytoma, Astrocytoma Trial in New York (Adaptive Radiotherapy)

Recruiting
  • Glioblastoma
  • +3 more
  • Adaptive Radiotherapy
  • New York, New York
    Columbia University Irving Medical Center
Oct 27, 2023

Testing Cerebrospinal Fluid for Cell-free Tumor DNA in Children,

Not yet recruiting
  • Anaplastic Astrocytoma
  • +17 more
    • (no location specified)
    Jun 28, 2023

    Diffuse Astrocytoma, Anaplastic Astrocytoma, Astrocytoma Trial in Worldwide (dabrafenib, trametinib)

    Recruiting
    • Diffuse Astrocytoma
    • +22 more
    • Phoenix, Arizona
    • +26 more
    Jan 27, 2023

    Recurrent High Grade Glioma, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma Trial (PCI 24781, Temozolomide)

    Not yet recruiting
    • Recurrent High Grade Glioma
    • +4 more
    • (no location specified)
    Jan 24, 2023

    Glioma, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma Trial in Duarte, Chicago (Neural stem cells loaded with an

    Completed
    Has Results
    • Glioma
    • +7 more
    • Neural stem cells loaded with an oncolytic adenovirus
    • Duarte, California
    • +1 more
    Dec 28, 2022

    Glioblastoma Multiforme, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma Trial in United States (INCB7839)

    Recruiting
    • Glioblastoma Multiforme
    • +5 more
    • Los Angeles, California
    • +12 more
    Jan 9, 2023

    Anaplastic Astrocytoma, IDH-Wildtype, Anaplastic Oligoastrocytoma, Anaplastic Oligodendroglioma Trial in Houston (other,

    Recruiting
    • Anaplastic Astrocytoma, IDH-Wildtype
    • +8 more
    • Quality-of-Life Assessment
    • +3 more
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 8, 2022

    Medulloblastoma, Glioblastoma Multiforme, Anaplastic Astrocytoma Trial in Buffalo, New York, Cincinnati (SurVaxM for patients

    Recruiting
    • Medulloblastoma
    • +7 more
    • SurVaxM for patients with relapsed or progressive MB, HGG or ependymoma ages ≥10 and ≤21 years
    • +2 more
    • Buffalo, New York
    • +2 more
    Jul 8, 2022

    Anaplastic Astrocytoma, Anaplastic Ependymoma, Anaplastic Oligodendroglioma Trial in United States (other, drug, procedure)

    Active, not recruiting
    • Anaplastic Astrocytoma
    • +6 more
    • Laboratory Biomarker Analysis
    • +4 more
    • Los Angeles, California
    • +11 more
    Jul 1, 2022

    Brain Tumor, Recurrent, Glioblastoma, Anaplastic Astrocytoma Trial in New York (Cytoreductive surgery, Perifosine, Temsirolimus)

    Active, not recruiting
    • Brain Tumor, Recurrent
    • +4 more
    • Cytoreductive surgery
    • +2 more
    • New York, New York
    • +1 more
    Jun 9, 2022

    Anaplastic Oligoastrocytoma, Anaplastic Oligodendroglioma, Mixed Glioma Trial in Minneapolis, Portland (Carboplatin, Etoposide,

    Completed
    • Anaplastic Oligoastrocytoma
    • +3 more
    • Minneapolis, Minnesota
    • +1 more
    Mar 11, 2022

    CNS Tumors, Glioblastoma, Gliosarcoma, Adult Trial run by the (ONC206)

    Recruiting
    • Central Nervous System Neoplasms
    • +22 more
    • Bethesda, Maryland
      National Institutes of Health
    Mar 1, 2022

    MicroRNA-10b in Patients With Gliomas

    Recruiting
    • Astrocytoma
    • +8 more
      • Boston, Massachusetts
      • +3 more
      May 30, 2021

      Grade II Glioma, Grade III Glioma, Grade IV Glioma Trial in Boston (Microdevice)

      Recruiting
      • Grade II Glioma
      • +7 more
      • Microdevice
      • Boston, Massachusetts
        Brigham and Women's Hospital
      Feb 22, 2021

      Anaplastic Oligodendroglioma, Oligoastrocytoma, Oligodendroglioma Trial in Los Angeles (Wear novoTTF-200A, Quality-of-Life

      Withdrawn
      • Anaplastic Oligodendroglioma
      • +2 more
      • Wear novoTTF-200A
      • Quality-of-Life Assessment
      • Los Angeles, California
        USC / Norris Comprehensive Cancer Center
      Dec 8, 2020

      Glioblastoma Multiforme, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma Trial run by the NCI (AZD8055)

      Completed
      • Glioblastoma Multiforme
      • +4 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Dec 11, 2019

      Magnetic Resonance Imaging and Magnetic Resonance Spectroscopy

      Withdrawn
      • Glioblastoma Multiforme
      • +2 more
      • MRS Spectroscopy
      • New York, New York
        Weill Cornell Medical College Department of Neurosurgery
      May 30, 2019

      (11C)dLop as a Marker of P-Glycoprotein Function in Gliomas

      Terminated
      • Low Grade Glioma
      • +4 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center, 9000 Rockville Pi
        Jul 3, 2018

        Glioblastoma Multiforme, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma Trial in United States (Toca 511, Toca FC)

        Completed
        • Glioblastoma Multiforme
        • +3 more
        • Toca 511
        • Toca FC
        • Irvine, California
        • +5 more
        May 16, 2018

        Glioblastoma Multiforme, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma Trial in United States (Toca 511 vector, Toca FC)

        Completed
        • Glioblastoma Multiforme
        • +3 more
        • Toca 511 vector
        • Toca FC
        • Los Angeles, California
        • +7 more
        May 16, 2018

        Anaplastic Astrocytoma, Anaplastic Oligodendroglioma, Anaplastic Oligoastrocytoma Trial in Omaha (dietary supplement, drug,

        Terminated
        Has Results
        • Anaplastic Astrocytoma
        • +4 more
        • ascorbic acid
        • +3 more
        • Omaha, Nebraska
          University of Nebraska Medical Center
        Jan 25, 2018

        Oligoastrocytoma, Mixed, Anaplastic Oligodendroglioma Trial in Columbus (Temozolomide)

        Completed
        • Oligoastrocytoma, Mixed
        • Anaplastic Oligodendroglioma
        • Columbus, Ohio
          Ohio State University
        Nov 28, 2017

        Teratoid Tumor, Atypical, Choroid Plexus Tumors, Anaplastic Astrocytoma Trial in United States (azurin-derived cell-penetrating

        Completed
        • Teratoid Tumor, Atypical
        • +9 more
        • azurin-derived cell-penetrating peptide p28
        • Los Angeles, California
        • +10 more
        Aug 3, 2017

        Anaplastic Astrocytoma, Anaplastic Oligoastrocytoma, Anaplastic Oligodendroglioma Trial in Buffalo (biological, other, drug)

        Completed
        • Anaplastic Astrocytoma
        • +64 more
        • DEC-205/NY-ESO-1 Fusion Protein CDX-1401
        • +3 more
        • Buffalo, New York
          Roswell Park Cancer Institute
        Oct 3, 2016

        Anaplastic Astrocytoma, Anaplastic Oligodendroglioma, Breast Cancer With Recurrent Brain Metastases Trial in Orange, San Antonio

        No longer available
        • Anaplastic Astrocytoma
        • +3 more
        • Orange, California
        • +1 more
        Jun 3, 2016